Extended Data Fig. 5: Performance evaluation of AI system in the prospective deployment study.
From: Optimized glycemic control of type 2 diabetes with reinforcement learning: a proof-of-concept trial
a, The user interface of AI deployment. b, Demographics and baseline measurements of patients in the deployment phase study (n = 20). BMI, body mass index; A1c, glycated hemoglobin. Numerical variables were reported as mean±SD.
